Keyphrases
Indonesia
66%
β-Thalassemia (β-thal)
64%
Thalassemia
50%
Deferiprone
33%
Hemophilia
20%
Risk Factors
20%
Zinc
20%
Jakarta
18%
Iron Chelator
18%
Iron Overload
17%
Retinal Changes
16%
Placebo Groups
15%
Severe Haemophilia A
15%
Splenectomy
15%
Ferritin Levels
14%
Quantitative PCR
14%
Neutrophil Count
13%
Monocytes
13%
Hemoglobin Level
12%
Deferasirox
12%
Neutrophil Phagocytosis
12%
Pre-transfusion Hemoglobin
11%
Serum Ferritin
11%
Immune Response
11%
Neutropenia
11%
Indonesian
11%
Low-dose Prophylaxis
10%
Diffusion Magnetic Resonance Imaging (dMRI)
10%
Factor VIII Prophylaxis
10%
Deferoxamine
10%
Retinal Findings
10%
Patient Evidence
10%
Dose Factor
10%
Transfusional Iron Overload
10%
Liquid Formulation
10%
Pattern Dystrophy
10%
Splenectomized Patient
10%
Joint Outcome
10%
Joint Bleeding
10%
TLR4 Expression
10%
Haemophilia Treatment Centre
10%
Episodic Treatment
10%
Immunocompromised children
10%
Motor Dysfunction
10%
Immune Thrombocytopenic Purpura
10%
Pediatric Leukemia
10%
Old Age
10%
Whole Genome
10%
Gross Motor
10%
Splenectomized
10%
Pharmacology, Toxicology and Pharmaceutical Science
Thalassemia
100%
Thalassemia Major
62%
Placebo
44%
Deferiprone
44%
Deferasirox
28%
Iron Chelating Agent
28%
Infection
23%
Iron Poisoning
21%
Ferritin
17%
Deferoxamine
13%
Monotherapy
13%
Neutropenia
11%
Antioxidant
11%
Haemophilia A
10%
Vaccination Policy
10%
Liquid Formulation
10%
Nonhodgkin Lymphoma
10%
Idiopathic Thrombocytopenic Purpura
10%
Leukemia
10%
SARS Coronavirus
10%
Toll Like Receptor 2
10%
Blood Clotting Factor 8
10%
Biological Marker
10%
Acetylcysteine
10%
Tolerability
10%
Randomized Controlled Trial
10%
Pharmacokinetics
10%
Newborn Sepsis
10%
Toll Like Receptor 4
10%
Epilepsy
10%
Iron
10%
Chelation Therapy
9%
Disease
9%
Malonaldehyde
8%
Pneumococcus Vaccine
8%
Coronavirinae
7%
CD8 Antigen
6%
Cross-Sectional Study
6%
Zinc Deficiency
6%
C Reactive Protein
5%
Agranulocytosis
5%
Bilirubin
5%
Acute Lymphoblastic Leukemia
5%
HIV
5%
Medicine and Dentistry
Thalassemia Major
23%
Thalassemia
21%
Haemophilia
20%
Cross Sectional Study
15%
Deferasirox
15%
COVID-19
15%
Leukemia
14%
Iron Overload
13%
Ferritin
12%
Pediatrics
11%
Magnetic Resonance Imaging
11%
Deferoxamine
10%
Deferiprone
10%
Dystrophy
10%
Lipid Pneumonia
10%
Adolescent
10%
Spastic Diplegia
10%
Stereotypic Movement Disorder
10%
Randomized Controlled Trial
10%
Virus Genome
10%
Whole Genome Sequencing
10%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Non-Hodgkin Lymphoma
10%
Infection
10%
Acetylcysteine
10%
Placebo
10%
Multiplex Ligation Dependent Probe Amplification
10%
Acute B-Cell Lymphoblastic Leukemia
10%
Kidney Function
10%
Iron
10%
Malignant Neoplasm
10%
Psychological Well-Being
10%
Glomerulus
8%
Haemophilia A
8%
Autofluorescence
6%
Retinal Pigment Epithelium
6%
Strengths and Difficulties Questionnaire
6%
Mental Health
6%
Retinoblastoma
6%
Ciclonicate
5%
Solid Malignant Neoplasm
5%
Iron Chelating Agent
5%
Bilirubin
5%
Acute Lymphoblastic Leukemia
5%
